Change of Auditor

In brief · summary, not quotable

Nuformix plc announced the appointment of Kreston Reeves Audit LLP as its new auditor. This decision follows a restructuring within Kreston Reeves LLP, the company's previous auditor. The appointment of Kreston Reeves Audit is contingent upon shareholder approval at the upcoming Annual General Meeting.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your NFX notes

Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces the appointment of Kreston Reeves Audit LLP ("Kreston Reeves Audit") as auditor to the Company. The appointment of Kreston Reeves Audit follows a restructuring of the audit practice of Kreston Reeves LLP, the Company's former auditor, and will be subject to approval by shareholders at the next Annual General Meeting of the Company.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.